title: Kidney disease in patients with chronic hepatitis C.
abstract: There is an increasing recognition of the association between chronic hepatitis C virus infection and glomerular diseases. Renal complications may be the presenting manifestation of hepatitis C virus infection. Patients may present with signs and symptoms of cryoglobulinemic systemic vasculitis, proteinuria, microscopic hematuria, acute renal failure, or nephrotic syndrome. The pathogenesis of hepatitis C virus associated with renal disease remains incompletely understood; however, deposition of circulating immune complexes in the subendothelial space and mesangium in the glomeruli seems to play a major role. The most common renal pathology associated with hepatitis C virus infection is type I membranoproliferative glomerulonephritis with or without cryoglobulinemia. In patents who do not have significant renal impairment, combination therapy with interferon alfa (IFN-alpha) and ribavirin seems to be the treatment of choice, although the experience with this combination is quite limited in patients with renal involvement. A prolonged course of high-dose IFN-alpha has been most commonly used for these patients with significant success, but relapse of hepatitis C viremia and renal disease after discontinuation of therapy have frequently occurred.
authors.affiliation: Division of Nephrology, Saint Louis University School of Medicine, 3635 Vista Avenue, St. Louis, MO 63110, USA. philipmd@slu.edu
authors.forename: M
authors.initials: M
authors.lastname: Philipneri
authors.forename: B
authors.initials: B
authors.lastname: Bastani
mesh_terms: D000936:Antigen-Antibody Complex; D000998:Antiviral Agents / Q000627:therapeutic use; D018450:Disease Progression; D005921:Glomerulonephritis / Q000209:etiology; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007674:Kidney Diseases / Q000209:etiology* / Q000276:immunology; D016030:Kidney Transplantation; D011183:Postoperative Complications; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000936:Antigen-Antibody Complex; D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin